Literature DB >> 24330850

Overexpression of Bmi-1 induces the malignant transformation of gastric epithelial cells in vitro.

Yinting Chen1, Guoda Lian, Qiubo Zhang, Linjuan Zeng, Chenchen Qian, Shaojie Chen, Kaihong Huang.   

Abstract

Oncogene Bmi-1 (B-cell-specific Moloney murine leukemia virus integration site 1) has attracted much attention for its involvement in the initiation of a variety of tumors. Our previous study showed that Bmi-1 was highly expressed in gastric cancer and correlated with patient prognosis. However, whether aberrant Bmi-1 expression was critical for the transformation of gastric epithelial cells remains unknown. In this study, we stably expressed Bmi-1 in a human gastric epithelial immortalized cell line, GES-1. The overexpression of Bmi-1 promoted cell growth and proliferation, inhibited apoptosis, enhanced clone formation capability, possessed the characteristics of anchorage-independent growth, and increased migration and invasion abilities. Therefore, our findings demonstrated that ectopic expression of Bmi-1 played an important role in the malignant transformation of gastric epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24330850     DOI: 10.3727/096504013X13786659070316

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  9 in total

1.  LncRNA CASC9 Suppressed the Apoptosis of Gastric Cancer Cells through Regulating BMI1.

Authors:  Jun Fang; Wei Chen; Xiang-Ling Meng
Journal:  Pathol Oncol Res       Date:  2019-10-22       Impact factor: 3.201

2.  BMI-1, a promising therapeutic target for human cancer.

Authors:  Min-Cong Wang; Chun-Li Li; Jie Cui; Min Jiao; Tao Wu; L I Jing; Ke-Jun Nan
Journal:  Oncol Lett       Date:  2015-06-11       Impact factor: 2.967

3.  Inverse association between Bmi-1 and RKIP affecting clinical outcome of gastric cancer and revealing the potential molecular mechanisms underlying tumor metastasis and chemotherapy resistance.

Authors:  Yinting Chen; Guoda Lian; Guangsheng Ou; Kege Yang; Jianning Chen; Haigang Li; Shaojie Chen; Jiajia Li; Linjuan Zeng; Kaihong Huang
Journal:  Gastric Cancer       Date:  2015-03-13       Impact factor: 7.370

4.  Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro.

Authors:  Shao-Jie Chen; Yin-Ting Chen; Lin-Juan Zeng; Qiu-Bo Zhang; Guo-da Lian; Jia-Jia Li; Ke-Ge Yang; Chu-Mei Huang; Ya-Qing Li; Zhong-Hua Chu; Kai-Hong Huang
Journal:  Tumour Biol       Date:  2016-03-08

5.  Circ0043898 acts as a tumor inhibitor and performs regulatory effect on the inhibition of esophageal carcinoma.

Authors:  Wei Wang; Jun Ma; Jianjun Lu; Danqing Fang; Xinming Xiong; Xin Yang; Tingting Xie
Journal:  Cancer Biol Ther       Date:  2018-09-25       Impact factor: 4.742

6.  Expression of Bmi-1 and PAI-1 in esophageal squamous cell carcinoma.

Authors:  Yan Zhang; Ya-Lou Zhang; Hong-Ming Chen; Hong-Wei Pu; Wen-Jing Ma; Xiao-Mei Li; Hong Ma; Xiao Chen
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

7.  MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1.

Authors:  Ting Wang; Tengfei Chen; Hua Niu; Chang Li; Chun Xu; Yuanyuan Li; Rui Huang; Jun Zhao; Shuyan Wu
Journal:  Int J Mol Med       Date:  2015-05-21       Impact factor: 4.101

8.  Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer.

Authors:  Yaqing Li; Zhenfeng Tian; Ying Tan; Guoda Lian; Shangxiang Chen; Shaojie Chen; Jiajia Li; Xuanna Li; Kaihong Huang; Yinting Chen
Journal:  Mol Cancer       Date:  2020-06-24       Impact factor: 27.401

9.  MAPK/c-Jun signaling pathway contributes to the upregulation of the anti-apoptotic proteins Bcl-2 and Bcl-xL induced by Epstein-Barr virus-encoded BARF1 in gastric carcinoma cells.

Authors:  Yuqiong Zhang; Meiqin Xu; Xueyi Zhang; Fuying Chu; Tianji Zhou
Journal:  Oncol Lett       Date:  2018-03-19       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.